Active substance
Fluphenazine
- SFDA 3
- US FDA 54
- Health Canada 3
- US price lines 5
- WHO EML 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| FLUPHENAZINE DECANOATE 25MG-ML Injection* | 25 mg/ml | Solution for injection · Intravenous use | 10 Ampoule | SAR 128.75 | NCE · Prescription | ANTIGEN | Withdrawn by MAH · Not Marketed |
| FLUPHENAZINE DECANOATE OILY 100MG-ML AMP | 100 mg/ml | Injection · Intramuscular use | 5 Ampoule | SAR 107.85 | NCE · Prescription | HOSPIRA AUSTRALIA | Withdrawn by MAH · Not Marketed |
| FLUPHENAZINE DECANOATE OILY 25MG-ML AMP | 25 mg/ml | Injection · Intramuscular use | 5 Ampoule | SAR 64.40 | NCE · Prescription | HOSPIRA AUSTRALIA | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| FLUPHENAZINE HYDROCHLORIDE | 2.5MG/ML | injectable · injection | FRESENIUS KABI USA | Prescription | 16 Apr 1987 |
| FLUPHENAZINE DECANOATE | 25MG/ML | injectable · injection | FRESENIUS KABI USA | Prescription | 14 Jul 1987 |
| FLUPHENAZINE HYDROCHLORIDE | 5MG | tablet · oral | SANDOZ | Prescription | 16 Oct 1987 |
| FLUPHENAZINE HYDROCHLORIDE | 1MG | tablet · oral | LANNETT | Prescription | 25 Aug 1988 |
| FLUPHENAZINE HYDROCHLORIDE | 2.5MG | tablet · oral | LANNETT | Prescription | 25 Aug 1988 |
| FLUPHENAZINE HYDROCHLORIDE | 5MG | tablet · oral | LANNETT | Prescription | 25 Aug 1988 |
| FLUPHENAZINE HYDROCHLORIDE | 10MG; 1MG; 2.5MG; 5MG | tablet · oral | LANNETT CO INC | Prescription | 25 Aug 1988 |
| FLUPHENAZINE HYDROCHLORIDE | 2.5MG/5ML | elixir · oral | PHARM ASSOC | Prescription | 21 Aug 1996 |
| FLUPHENAZINE DECANOATE | 25MG/ML | injectable · injection | HIKMA PHARMS | Prescription | 30 Aug 1996 |
| FLUPHENAZINE HYDROCHLORIDE | 5MG/ML | concentrate · oral | PHARM ASSOC | Prescription | 16 Sep 1996 |
| FLUPHENAZINE DECANOATE | 25MG/ML | injectable · injection | MYLAN LABS LTD | Prescription | 17 Aug 2001 |
| FLUPHENAZINE DECANOATE | 25MG/ML | injectable · injection | PH HEALTH | Prescription | 3 Jul 2014 |
| FLUPHENAZINE DECANOATE | 25MG/ML | injectable · injection | EUGIA PHARMA | Prescription | 17 Oct 2017 |
| FLUPHENAZINE HYDROCHLORIDE | 1MG; 2.5MG; 5MG; 10MG | tablet · oral | AMNEAL | Prescription | 9 Jul 2020 |
| FLUPHENAZINE HYDROCHLORIDE | 1MG; 2.5MG; 5MG; 10MG | tablet · oral | DR REDDYS | Prescription | 7 Jan 2021 |
| FLUPHENAZINE HYDROCHLORIDE | 1MG; 2.5MG; 5MG; 10MG | tablet · oral | NOVITIUM PHARMA | Prescription | 1 Mar 2021 |
| FLUPHENAZINE HYDROCHLORIDE | 1MG; 2.5MG; 5MG; 10MG | tablet · oral | ZYDUS LIFESCIENCES | Prescription | 27 May 2021 |
| FLUPHENAZINE HYDROCHLORIDE | 1MG; 2.5MG; 5MG; 10MG | tablet · oral | CHARTWELL RX | Prescription | 20 Oct 2021 |
| FLUPHENAZINE HYDROCHLORIDE | 1MG; 2.5MG; 5MG; 10MG | tablet · oral | TARO | Prescription | 14 Apr 2022 |
| FLUPHENAZINE HYDROCHLORIDE | 1MG; 2.5MG; 5MG; 10MG | tablet · oral | UPSHER SMITH LABS | Prescription | 24 Oct 2022 |
| FLUPHENAZINE HYDROCHLORIDE | 1MG; 2.5MG; 5MG; 10MG | tablet · oral | AJANTA PHARMA LTD | Prescription | 5 Jan 2023 |
| FLUPHENAZINE DECANOATE | 25MG/ML | injectable · injection | GLAND | Prescription | 30 Mar 2023 |
| FLUPHENAZINE HYDROCHLORIDE | 1MG; 2.5MG; 5MG; 10MG | tablet · oral | AUROBINDO PHARMA LTD | Prescription | 18 Aug 2023 |
| FLUPHENAZINE HYDROCHLORIDE | 1MG; 2.5MG; 5MG; 10MG | tablet · oral | MSN | Prescription | 11 Sep 2023 |
| FLUPHENAZINE DECANOATE | 25MG/ML | injectable · injection | MSN | Prescription | 2 Nov 2023 |
29 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| FLUPHENAZINE | 00405345 | 1 MG | TABLET · ORAL | AA PHARMA INC |
| FLUPHENAZINE | 00405361 | 5 MG | TABLET · ORAL | AA PHARMA INC |
| FLUPHENAZINE | 00410632 | 2 MG | TABLET · ORAL | AA PHARMA INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | FLUPHENAZINE 1 MG TABLET | $0.2128 | per EA | 23 Sep 2026 |
| US NADAC | FLUPHENAZINE 10 MG TABLET | $0.43085 | per EA | 23 Sep 2026 |
| US NADAC | FLUPHENAZINE 2.5 MG TABLET | $0.22373 | per EA | 23 Sep 2026 |
| US NADAC | FLUPHENAZINE 5 MG TABLET | $0.14825 | per EA | 23 Sep 2026 |
| US NADAC | FLUPHENAZINE DEC 125 MG/5 ML | $10.84399 | per ML | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 24.1. Medicines for psychotic disorders · core
Schizophrenia or other primary psychotic disorders
Parenteral > General injections > IM: 25 mg per mL in ampoule (decanoate); 25 mg per mL in ampoule (enanthate)
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.